THE POTENTIAL OF CHIMERIC ANTIGEN RECEPTOR T CELL (CART-T CELL) TARGETTING PROSTATE-SPECIFIC MEMRANE ANTIGEN (PSMA) MODIFIED BY CRISPR/CAS9 AS PROSTATE CANCER THERAPY. JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, [S. l.], v. 9, n. 1, p. 23–37, 2021. DOI: 10.53366/jimki.v9i1.321. Disponível em: https://jimki.bapin.or.id/main/article/view/321. Acesso em: 15 jun. 2026.